Adiponectin reverses β-Cell damage and impaired insulin secretion induced by obesity.


Journal

Aging cell
ISSN: 1474-9726
Titre abrégé: Aging Cell
Pays: England
ID NLM: 101130839

Informations de publication

Date de publication:
06 2023
Historique:
revised: 11 03 2023
received: 25 08 2022
accepted: 14 03 2023
medline: 15 6 2023
pubmed: 16 4 2023
entrez: 15 4 2023
Statut: ppublish

Résumé

Obesity significantly decreases life expectancy and increases the incidence of age-related dysfunctions, including β-cell dysregulation leading to inadequate insulin secretion. Here, we show that diluted plasma from obese human donors acutely impairs β-cell integrity and insulin secretion relative to plasma from lean subjects. Similar results were observed with diluted sera from obese rats fed ad libitum, when compared to sera from lean, calorically restricted, animals. The damaging effects of obese circulating factors on β-cells occurs in the absence of nutrient overload, and mechanistically involves mitochondrial dysfunction, limiting glucose-supported oxidative phosphorylation and ATP production. We demonstrate that increased levels of adiponectin, as found in lean plasma, are the protective characteristic preserving β-cell function; indeed, sera from adiponectin knockout mice limits β-cell metabolic fluxes relative to controls. Furthermore, oxidative phosphorylation and glucose-sensitive insulin secretion, which are completely abrogated in the absence of this hormone, are restored by the presence of adiponectin alone, surprisingly even in the absence of other serological components, for both the insulin-secreting INS1 cell line and primary islets. The addition of adiponectin to cells treated with plasma from obese donors completely restored β-cell functional integrity, indicating the lack of this hormone was causative of the dysfunction. Overall, our results demonstrate that low circulating adiponectin is a key damaging element for β-cells, and suggest strong therapeutic potential for the modulation of the adiponectin signaling pathway in the prevention of age-related β-cell dysfunction.

Identifiants

pubmed: 37060190
doi: 10.1111/acel.13827
pmc: PMC10265168
doi:

Substances chimiques

Adiponectin 0
Insulin 0
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13827

Informations de copyright

© 2023 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd.

Références

Clinics (Sao Paulo). 2006 Oct;61(5):433-40
pubmed: 17072441
Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6127-33
pubmed: 20194732
J Biol Chem. 2003 Mar 14;278(11):9073-85
pubmed: 12496257
Diabetes Res Clin Pract. 2019 Nov;157:107843
pubmed: 31518657
Cell Metab. 2020 Jul 7;32(1):100-116.e4
pubmed: 32413334
Endocrinology. 2008 May;149(5):2270-82
pubmed: 18202126
J Biol Chem. 2002 Jul 19;277(29):25863-6
pubmed: 12032136
Mediators Inflamm. 2009;2009:959281
pubmed: 19707530
Nat Rev Immunol. 2011 Feb;11(2):85-97
pubmed: 21252989
Endocrinology. 2008 Nov;149(11):5401-14
pubmed: 18599550
Diabetes. 2009 Oct;58(10):2303-15
pubmed: 19581419
J Nutr Biochem. 2012 Aug;23(8):867-74
pubmed: 21852089
EMBO Mol Med. 2022 Jan 11;14(1):e14418
pubmed: 34779138
Diabetes Care. 2003 Aug;26(8):2442-50
pubmed: 12882876
Biochem Biophys Res Commun. 1999 Apr 2;257(1):79-83
pubmed: 10092513
Diabetes Care. 2006 Nov;29(11):2498-503
pubmed: 17065691
Am J Physiol Endocrinol Metab. 2006 Aug;291(2):E388-94
pubmed: 16595853
FEBS J. 2016 Mar;283(5):822-33
pubmed: 26732506
Diabetes Care. 2006 Jun;29(6):1357-62
pubmed: 16732021
J Biol Chem. 2010 Oct 29;285(44):33623-31
pubmed: 20709750
J Nutr. 1993 Nov;123(11):1939-51
pubmed: 8229312
Endocr Rev. 2016 Jun;37(3):278-316
pubmed: 27159875
PLoS One. 2012;7(2):e31155
pubmed: 22319612
Sci Rep. 2018 Jan 10;8(1):406
pubmed: 29321603
Mol Biol Cell. 2011 Jul 1;22(13):2235-45
pubmed: 21551073
Diabetes Res Clin Pract. 2007 Feb;75(2):235-40
pubmed: 16872712
Diabetes. 2002 Sep;51(9):2734-41
pubmed: 12196466
PLoS One. 2008 Sep 15;3(9):e3211
pubmed: 18791640
Lancet. 2011 Aug 27;378(9793):815-25
pubmed: 21872750
Anal Biochem. 2010 Nov 15;406(2):105-12
pubmed: 20655863
J Proteome Res. 2022 Apr 1;21(4):1061-1072
pubmed: 35271285
Nat Med. 2004 May;10(5):524-9
pubmed: 15077108
Neurochem Res. 2018 Feb;43(2):316-323
pubmed: 29098530
Ageing Res Rev. 2010 Oct;9(4):424-30
pubmed: 20493280
J Biol Chem. 2006 Feb 3;281(5):2654-60
pubmed: 16326714
Aging Cell. 2023 Jun;22(6):e13827
pubmed: 37060190
Mol Metab. 2020 May;35:100957
pubmed: 32244188
J Biol Chem. 2003 Oct 10;278(41):40352-63
pubmed: 12878598
Sci Rep. 2021 Mar 22;11(1):6487
pubmed: 33753773
Elife. 2021 Apr 27;10:
pubmed: 33904399
Biochem Biophys Res Commun. 2014 Jun 6;448(3):261-6
pubmed: 24792183
PLoS One. 2011;6(7):e21230
pubmed: 21760889
Aging (Albany NY). 2015 Mar;7(3):152-66
pubmed: 25855056
J Biol Chem. 2003 Dec 12;278(50):50810-7
pubmed: 14522956
Int J Obes (Lond). 2007 May;31(5):770-6
pubmed: 17117187
Nature. 2006 Dec 14;444(7121):840-6
pubmed: 17167471
Eur J Endocrinol. 2013 Feb 15;168(3):385-91
pubmed: 23230211
J Clin Endocrinol Metab. 2001 Aug;86(8):3815-9
pubmed: 11502817
Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1595-9
pubmed: 10845877
J Clin Endocrinol Metab. 2004 Jun;89(6):2697-703
pubmed: 15181044
Int J Mol Sci. 2015 Dec 25;17(1):
pubmed: 26712749
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):2005-10
pubmed: 11172066
J Mol Biol. 2020 Mar 6;432(5):1461-1493
pubmed: 31634466
Front Physiol. 2019 Feb 05;9:1958
pubmed: 30804813
Circulation. 2019 Feb 19;139(8):1025-1035
pubmed: 30779652
Nat Med. 2001 Aug;7(8):941-6
pubmed: 11479627
Nat Commun. 2017 Jan 17;8:14063
pubmed: 28094793
Diabetologia. 2005 Jun;48(6):1084-7
pubmed: 15902402
Diabetologia. 2003 Jan;46(1):3-19
pubmed: 12637977
Science. 2005 Oct 14;310(5746):314-7
pubmed: 16224023
Nat Med. 2002 Jul;8(7):731-7
pubmed: 12068289
J Nutr. 1986 Apr;116(4):641-54
pubmed: 3958810
Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E210-8
pubmed: 17389708
Mol Aspects Med. 2020 Feb;71:100843
pubmed: 31918997
Eur J Endocrinol. 2005 Jul;153(1):91-8
pubmed: 15994750
Nature. 2001 Jan 18;409(6818):307-12
pubmed: 11201732
J Lipid Res. 2021;62:100095
pubmed: 34214600
Pharmacoeconomics. 2015 Jul;33(7):673-89
pubmed: 25471927

Auteurs

Ana Cláudia Munhoz (AC)

Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brazil.

Julian D C Serna (JDC)

Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brazil.

Eloisa Aparecida Vilas-Boas (EA)

Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brazil.

Camille C Caldeira da Silva (CC)

Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brazil.

Tiago G Santos (TG)

Centro Internacional de Pesquisa (CIPE), A. C. Camargo Cancer Center, São Paulo, Brazil.

Francielle C Mosele (FC)

Instituto de Biociências de Botucatu (IBB), Universidade Estadual Paulista (UNESP), Botucatu, Brazil.

Sergio L Felisbino (SL)

Instituto de Biociências de Botucatu (IBB), Universidade Estadual Paulista (UNESP), Botucatu, Brazil.

Vilma Regina Martins (VR)

Centro Internacional de Pesquisa (CIPE), A. C. Camargo Cancer Center, São Paulo, Brazil.

Alicia J Kowaltowski (AJ)

Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH